Jeong-Guen Kim

Title: Jeong-Guen Kim: Innovator in Pharmaceutical Chemistry

Introduction

Jeong-Guen Kim is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of isoxazole derivatives. His work focuses on innovative solutions for treating various metabolic and liver diseases.

Latest Patents

Jeong-Guen Kim holds 2 patents that highlight his expertise in the pharmaceutical domain. His latest patents include "Isoxazole derivatives as nuclear receptor agonists and uses thereof." This invention provides methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis. It involves administering a therapeutically effective amount of a pharmaceutical composition comprising an isoxazole derivative or its acceptable salts. Another patent under his name also relates to isoxazole derivatives, emphasizing their pharmaceutical compositions and preparation methods for activating the Farnesoid X receptor (FXR, NR1H4).

Career Highlights

Jeong-Guen Kim is currently associated with Il Dong Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to developing effective treatments that address critical health issues.

Collaborations

Some of his notable coworkers include Jae-Hoon Kang and Hong-Sub Lee, who collaborate with him on various projects within the pharmaceutical sector.

Conclusion

Jeong-Guen Kim's contributions to pharmaceutical chemistry, particularly through his innovative patents, demonstrate his dedication to improving health outcomes. His work continues to influence the development of new treatments for complex diseases.